Samuel J. Trammell

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of interorganellar lipid cycling.

Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of interorganellar lipid cycling.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of interorganellar lipid cycling.

Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of interorganellar lipid cycling.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Chronic, but not acute, treatment with GLP-2 and GIP in combination increases glucose absorption in the isolated vascularly perfused rat intestine.

Chronic, but not acute, treatment with GLP-2 and GIP in combination increases glucose absorption in the isolated vascularly perfused rat intestine.

Journal: Physiological reports
Published: February 16, 2026

The bile acid-CoA ligase, FATP5, is necessary for the synthesis of N-acyl taurines in the liver.

The bile acid-CoA ligase, FATP5, is necessary for the synthesis of N-acyl taurines in the liver.

Journal: Journal of lipid research
Published: November 23, 2025

Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese mice.

Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese mice.

Journal: Peptides
Published: November 03, 2025

Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study.

Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study.

Journal: Diabetes
Published: October 28, 2025

Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.

Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.

Journal: Journal of hepatology
Published: August 11, 2025

Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.

Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.

Journal: Journal of hepatology
Published: August 11, 2025

Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis.

Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis.

Journal: Diabetes
Published: April 09, 2024

Glucagon Resistance in Individuals With Obesity and Hepatic Steatosis Can Be Measured Using the GLUSENTIC Test and Index.

Glucagon Resistance in Individuals With Obesity and Hepatic Steatosis Can Be Measured Using the GLUSENTIC Test and Index.

Journal: Diabetes
Published: October 25, 2023

Identification of bile acid-CoA:amino acid N-acyltransferase as the hepatic N-acyl taurine synthase for polyunsaturated fatty acids.

Identification of bile acid-CoA:amino acid N-acyltransferase as the hepatic N-acyl taurine synthase for polyunsaturated fatty acids.

Journal: Journal of lipid research
Published: February 23, 2023

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells.

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells.

Journal: iScience
Published: July 21, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026